logo
Plus   Neg
Share
Email

Regions Financial Q4 Profit Rises 61%, Results Top Estimates - Quick Facts

Regions Financial Corp. (RF) on Friday reported fourth-quarter net income available to common shareholders increased to $588 million or $0.61 per share from $366 million or $0.38 per share in the year-ago quarter.

Total revenue for the quarter rose 13.9 percent to $1.69 billion from $1.48 billion in the same quarter last year, reflecting growth in both net interest income and non-interest income. Adjusted total revenue also rose 11.7 percent to $1.66 billion from $1.48 billion last year.

On average, analysts polled by Thomson Financial expected the company to report earnings of $0.42 per share on revenues of $1.56 billion for the quarter. Analysts' estimates typically exclude special items.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration granted emergency use authorization (EUA) for the first and only clinical T cell-based test for patients to detect the unique T-cell signature specific to SARS-CoV-2, the virus that causes COVID-19. The test confirms recent or prior COVID-19 infection. Developed by Adaptive Biotechnologies, T-Detect COVID Test is a next generation sequencing based (NGS) test. AstraZeneca's one batch of Covid vaccine has been suspended by Austrian health authorities following reports of a death and an illness after receiving vaccination, reports said. The issues were reported in the district clinic of Zwettl in Lower Austria province. The Federal Office for Safety in Health Care in the country said the remaining stocks of the affected AstraZeneca/Oxford Covid-19 vaccine DuPont (DD) announced Monday that it has agreed to acquire Laird Performance Materials from with private equity firm Advent International for $2.3 billion. The company will use existing cash balances for the acquisition. The transaction is expected to close in the third quarter of 2021, subject to regulatory...
Follow RTT